Vaxcyte Inc (PCVX)
34.75 x 1 35.03 x 1
Post-market by (Cboe BZX)
34.77 +1.87 (+5.68%) 04/29/25 [NASDAQ]
34.75 x 1 35.03 x 1
Post-market 34.77 unch (unch) 16:32 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | PCVX | ALKS | RYTM | ||
Company | Vaxcyte Inc | Alkermes Plc | Rhythm Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 32.72 | 27.76 | 63.73 | ||
High | 34.90 | 28.88 | 65.53 | ||
Low | 32.27 | 27.76 | 63.50 | ||
Last | 34.77 | 28.77 | 65.22 | ||
Change | +1.87 | +0.86 | +0.81 | ||
% Change | +5.68% | +3.08% | +1.26% | ||
Volume | 1,274,300 | 1,871,700 | 364,100 | ||
20-Day Average Volume | 3,268,210 | 1,938,060 | 995,575 | ||
Previous Close | 32.90 | 27.91 | 64.41 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 31.64 | 28.51 | 58.51 | ||
20-Day Raw Stochastic | 69.30% | 40.53% | 98.42% | ||
20-Day Relative Strength | 34.75% | 42.86% | 62.66% | ||
Weighted Alpha | -32.27 | +12.59 | +24.66 | ||
Today's Opinion | 88% Sell | 24% Sell | 72% Buy | ||
Previous Opinion | 88% Sell | 40% Sell | 72% Buy | ||
Last Month's Opinion | 100% Sell | 64% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +11.23% since 04/22/25 | +6.12% since 04/22/25 | +10.11% since 04/22/25 | ||
Low | 31.99 on 04/25/25 | 26.86 on 04/23/25 | 59.03 on 04/23/25 | ||
High | 34.90 on 04/29/25 | 28.88 on 04/29/25 | 65.53 on 04/29/25 | ||
1-Month | |||||
%Chg | -49.94% since 03/28/25 | -13.37% since 03/28/25 | +19.01% since 03/28/25 | ||
Low | 27.66 on 04/10/25 | 25.56 on 04/10/25 | 45.90 on 04/07/25 | ||
High | 37.94 on 03/31/25 | 33.48 on 04/01/25 | 65.53 on 04/29/25 | ||
3-Month | |||||
%Chg | -60.79% since 01/29/25 | -8.84% since 01/29/25 | +14.04% since 01/29/25 | ||
Low | 27.66 on 04/10/25 | 25.56 on 04/10/25 | 45.90 on 04/07/25 | ||
High | 92.58 on 01/30/25 | 36.45 on 02/18/25 | 65.53 on 04/29/25 | ||
6-Month | |||||
%Chg | -67.06% since 10/29/24 | +8.81% since 10/29/24 | +31.65% since 10/29/24 | ||
Low | 27.66 on 04/10/25 | 25.56 on 04/10/25 | 45.90 on 04/07/25 | ||
High | 116.00 on 11/06/24 | 36.45 on 02/18/25 | 68.58 on 11/11/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 4,242,093 | 4,600,572 | 4,072,258 | ||
Shares Outstanding, K | 128,939 | 164,836 | 63,224 | ||
Annual Sales | 0 | 1,557,630,000 | 130,130,000 | ||
Annual Net Income | -463,930,000 | 367,070,000 | -260,600,000 | ||
Last Quarter Sales | 0 | 429,990,000 | 41,830,000 | ||
Last Quarter Net Income | -137,080,000 | 146,500,000 | -43,330,000 | ||
60-Month Beta | 1.26 | 0.39 | 2.32 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.02 on 02/25/25 | 1.04 on 02/12/25 | -0.72 on 02/26/25 | ||
Latest Earnings Date | 05/14/25 | 05/01/25 | 05/07/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 11.50 | 0.00 |